Nearly half a trillion dollars — $421 billion to be exact — that’s how much the world’s 100 largest medical device companies brought in over the past year amid the COVID-19 pandemic. That’s one of the big takeaways from the Big 100, MassDevice and Medical Design & Outsourcing‘s annual analysis of the worlds’ 100 largest medtech companies. (Check […]
Hologic
Hologic beats the Street after an unprecedented year
Hologic (NSDQ:HOLX) posted fourth-quarter results today that handily beat the consensus forecast on Wall Street, concluding an impressive year of growth on the back of robust COVID-19 testing revenue. The Marlborough, Massachusetts–based diagnostics and women’s health company reported quarterly profits of $328.8 million — or $1.28 per diluted share — on sales of nearly $1.32 […]
Hologic CEO Steve MacMillan salutes CFO Karleen Oberton, offers his outlook and talks M&A
After interviewing Hologic CFO Karleen Oberton for Medical Design & Outsourcing‘s annual Women in Medtech issue, we connected with CEO Steve MacMillan to get his take. He offered praise for his finance chief’s leadership throughout the pandemic, shared his outlook for the Marlborough, Massachusetts–based company’s future and discussed the M&A strategy for Hologic (NSDQ:HOLX), which […]
Hologic plans to buy Bolder Surgical for $160M
Hologic Inc. (NSDQ:HOLX) said today that it has a $160 million deal to acquire Bolder Surgical, a developer and manufacturer of advanced energy vessel-sealing surgical devices. Louisville, Colorado–based Bolder Surgical’s laparoscopic vessel sealing, dividing and dissecting devices will join Hologic’s surgical portfolio when the deal closes, expected by the end of 2021. Marlborough, Massachusetts–based Hologic […]
Hologic launches on-demand molecular testing in Europe
Hologic (Nasdaq: HOLX) announced today that it launched its Novodiag fully automated molecular diagnostic system in Europe. Marlborough, Massachusetts-based Hologic designed its Novodiag system for the on-demand testing of infectious diseases and antimicrobial resistance. The launch follows the company’s $795 million acquisition of Mobidiag this past summer. According to a news release, the Novodiag system […]
Hologic expands Omni hysteroscopy offering in Europe
Hologic (Nasdaq: HOLX) announced today that it has expanded its Omni suite of gynecological surgical offerings in Europe, Africa and western Asia. The Omni expansion gives physicians greater flexibility and choice as they optimize diagnostic and operative hysteroscopy, according to the Marlborough, Massachusetts–based women’s health company. “The option to ‘see and treat’ is becoming more […]
Hologic’s first Global Women’s Health Index flags preventative care for improvement
An estimated 1.5 billion women have not been tested in the past year for critical diseases, according to Hologic’s first Global Women’s Health Index. On behalf of diagnostic maker Hologic, the Gallup World Poll surveyed more than 60,000 women and girls (age 15 and older) across the world to measure action and attitudes about women’s […]
MedTech 100 roundup: Industry climbs with earnings season in full swing
Better-than-expected quarterly earnings are providing a further boost to medtech industry stocks. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 30) at 118.86 points. Two weeks ago aside — when the index shot up to 145.88 points and quickly tumbled down — this mark […]
Hologic beats The Street as Q3 profits nearly double
Hologic (NSDQ:HOLX) posted third-quarter results that beat the overall consensus on Wall Street. The Marlborough, Mass.-based women’s health and diagnostics tech company reported profits of $268.1 million, or $1.04 per share, on sales of $1.2 billion for the three months ended June 26. The results out yesterday evening represented a bottom-line gain of 96.6% on […]
How COVID-19 changed medical device clinical trials forever
The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on […]
SCOTUS preserves assignor estoppel in Minerva Surgical v. Hologic patent case
The U.S. Supreme Court, in its Minerva Surgical v. Hologic ruling today preserved the legal doctrine of assignor estoppel — that inventors who sell patent rights can’t then claim they’re invalid. However, Justice Elena Kagan, in her opinion for the majority, did say that the doctrine has limits. Get the full story on our sister […]
